Bill Text: HI HB1794 | 2022 | Regular Session | Introduced
Bill Title: Relating To Opioids.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced - Dead) 2022-02-17 - Report adopted. referred to the committee(s) on CPC as amended in HD 2 with Representative(s) Kapela voting aye with reservations; none voting no (0) and none excused (0). [HB1794 Detail]
Download: Hawaii-2022-HB1794-Introduced.html
HOUSE OF REPRESENTATIVES |
H.B. NO. |
1794 |
THIRTY-FIRST LEGISLATURE, 2022 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
||
|
A BILL FOR AN ACT
RELATING TO OPIOIDS.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Chapter 329E, Hawaii Revised Statutes, is amended by adding a new section to be appropriately designated and to read as follows:
"§329E- Opioids; standardized metrics; value-based purchasing. (a)
By January 1, 2023, the department of health
shall develop and implement standardized quality metrics
to track and address health care processes and outcomes applicable to:
(1) The improvement of the quality of care;
and
(2) Targeting, through value-based purchasing,
improvement in outcomes,
for patients having
opioid use disorders.
(b)
The quality metrics shall adhere to all applicable
regulations and standards established by the federal Substance Abuse and Mental
Health Services Administration.
(c) By
July 1, 2023, the department of health shall implement value-based
purchasing based on the standardized quality metrics developed pursuant to subsection
(a). The value-based purchasing shall
be applicable to all state purchases of health and human services entered into after
July 1, 2023.
(d) The
department of health shall require health service providers to collect and report
to the department the following information:
(1) Levels of prescribed
opioids, including opioids dispensed for in-patient and emergency department use;
(2) Inpatient and emergency
department use for opioid use disorders;
(3) Duration of medications
for opioid use disorder pharmacotherapy;
(4) Retention in treatment;
and
(5) Counseling rates.
(e) No
less than twenty days prior to the convening of each regular session, the department
of health shall submit to the legislature an annual report that includes:
(1) A compilation of
the data compiled pursuant to subsection (d); and
(2) An update on the
implementation of value-based purchasing."
(f) As
used in this section, "value-based purchasing" means a system that correlates
payments to providers with measures of quality of care and outcomes delivered."
SECTION 2. This Act does not affect rights and duties that matured, penalties that were incurred, and proceedings that were begun before its effective date.
SECTION 3. New statutory material is underscored.
SECTION 4. This Act shall take effect upon its approval.
INTRODUCED BY: |
_____________________________ |
|
|
Report Title:
DOH; Opioids; Standardized Metrics; Value-Based Purchasing; Patient Outcomes
Description:
Requires the Department of Health to implement standardized quality metrics to track and address health care processes or outcomes applicable to improving the quality of care for patients having opioid use disorders and targeting through value-based purchasing improvements in outcomes for patients having opioid use disorders. Requires the Department of Health to implement value-based purchasing based on the standardized quality metrics. Directs the Department of Health to collect data on levels of opioid prescriptions, use of opioids in healthcare settings, and patient interactions for opioid use disorders. Requires annual reports to the Legislature.
The summary description
of legislation appearing on this page is for informational purposes only and is
not legislation or evidence of legislative intent.